Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cerence ( (CRNC) ) has shared an announcement.
Cerence, a company involved in patent disputes with Samsung, resolved its legal battles through a cross-license agreement. This agreement, reached on October 28, 2025, required Samsung to make a one-time payment of $49.5 million to Cerence, concluding a series of lawsuits filed by both parties over patent infringements.
The most recent analyst rating on (CRNC) stock is a Hold with a $11.00 price target. To see the full list of analyst forecasts on Cerence stock, see the CRNC Stock Forecast page.
Spark’s Take on CRNC Stock
According to Spark, TipRanks’ AI Analyst, CRNC is a Neutral.
Cerence’s overall stock score is driven by a strong earnings call that highlighted revenue exceeding guidance and strategic advancements in AI. However, significant financial challenges, particularly in profitability and leverage, weigh heavily on the score. The technical analysis and valuation further reflect a cautious outlook, with negative momentum and unattractive valuation metrics.
To see Spark’s full report on CRNC stock, click here.
More about Cerence
Average Trading Volume: 2,152,206
Technical Sentiment Signal: Buy
Current Market Cap: $464.8M
Learn more about CRNC stock on TipRanks’ Stock Analysis page.